Viatrexx-Derma

Product NDC

73069-108

11-digit product format

730690108

Labeler code

73069

Product ID

73069-108_5f431a4a-02ed-4eec-99da-2d3fef3b3348

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Anti-Interleukin 1, Ankle Articulations, Beta Endorphin, bFGF, Calcaneal tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming GF-Beta

Dosage form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS

Labeler

VIATREXX BIO INCORPORATED

Marketing category

UNAPPROVED DRUG OTHER

Marketing start

2019-03-29

Marketing end

0000-00-00

Substance

BASIC FIBROBLAST GROWTH FACTOR (HUMAN); CALCIUM GLUCONATE; CENTELLA ASIATICA; PORK COLLAGEN; HYALURONIDASE; MECASERMIN; BOS TAURUS PLACENTA; SUS SCROFA PLACENTA

Active strength

200 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL

Pharmacologic classes

Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Endoglycosidase [EPC],Glycoside Hydrolases [CS]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record